MegaRobo Raises $300 Million for Automated Drug Lab Systems and Robots

MegaRobo Technologies of Beijing closed a $300 million C round financing to develop automated systems for drug R&D and other uses. Its MegaLab offers a fully automatic lab. The company’s modular systems integrate machine vision and artificial intelligence. Its robots include embedded connectivity capabilities, so every robot operates as a data-gathering terminal by transmitting real-time data to the MegaCloud platform, with AI-based algorithms processing the data. The system can monitor equipment, predict maintenance needs and manage risk. The C round was led by Goldman Sachs Asset Management, Asia Investment Capital and GGV Capital. More details....

Share this with colleagues: